regulatory
confidence high
sentiment negative
materiality 0.70
SinglePoint Inc.: Nasdaq/NYSE listing notice — SinglePoint receives Cboe BZX minimum bid price deficiency notice; 180-day cure period until Aug 26, 2024
SinglePoint Inc.
- Received Cboe BZX notification on Feb 28, 2024 that common stock did not maintain $1.00 minimum bid price for 30 consecutive business days.
- Has 180 days (until Aug 26, 2024) to regain compliance by achieving $1.00 closing bid for 10 consecutive business days.
- If not cured, may be eligible for additional 180-day grace period if other listing standards are met.
- CEO states company is undervalued with $2M market cap vs $25M+ revenue; plans to address deficiency.
- No immediate effect on trading under symbol SING.